Antimicrobial resistance—when bacteria and fungi defend themselves against the drugs designed to kill them—is an urgent ...
News Medical on MSN
Mouse study reveals mechanism driving first night insomnia
You check into a hotel and toss and turn all night, but your sleep improves the following night. Scientists at Nagoya University wanted to understand why this happens. Working with mice, they have ...
Polaryx Therapeutics ("Polaryx" or the "Company") a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, ...
New research from the University of St Andrews has discovered that vertebrates make higher numbers of different forms of ...
Combined AI and Experimental Validation Platform Enables End-to-End Protein Binder Discovery in 1-2 WeeksSAN CARLOS, Calif.-- ...
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...
Galderma (SIX: GALD) today announced that the U.S. FDA has accepted the BLA resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and ...
Ciro Leonardo Pierri, co-founder of MitoCareX Bio Ltd. (“MitoCareX Bio”), a specialty biotechnology company developing small‑molecule drugs that target human mitochondrial carriers, its wholly- owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results